Sirona Medical Raises $40M Series D as Platform Usage Triples
Round led by Avidity Partners. Platform usage, ARR, & contracted ARR all grew by more than 2.5x year-over-year.…
New composite outcomes data show patients treated with Lilly’s Omvoh (mirikizumab-mrkz) achieved comprehensive corticosteroid-free disease control in ulcerative colitis and corticosteroid-free deep remission in Crohn’s disease at one year
In LUCENT-2, more than one in four (27.7%) Omvoh-treated patients with ulcerative colitis achieved comprehensive disease control, a…
Study Evaluates Dental Suction Devices for Reducing Oral Surgical Fire Risk
“This study aims to compare the adequacy of the high volume evacuation (HVE), Yankauer (YS), and saliva ejector…
BillionToOne’s Northstar Response® Is a Stronger Predictor of Immunotherapy Outcomes Than Standard-of-Care Imaging for Cancer Patients in Peer-Reviewed Study
Tissue-free ctDNA monitoring was the dominant independent predictor of survival across 12 tumor types and two prospective cohorts…
Zimmer Biomet Appoints Dr. Jonathan M. Vigdorchik as Chief Science, Technology and Medical Affairs Officer
Experienced orthopedic surgeon from the Hospital for Special Surgery, innovator and former Chief Medical Technology Advisor joins company…
Astronaut whose medical issue prompted NASA’s first early return from the ISS speaks out
Veteran NASA astronaut Mike Fincke has confirmed that he was the crew member who had a concerning “medical…
GE HealthCare to Acquire Intelerad for $2.3 Billion
GE HealthCare GEHC 2.27%increase; green up pointing triangle Technologies will buy medical imaging software provider Intelerad for $2.3…
NEUROMARK® Treatment for Chronic Rhinitis Demonstrates Durable 2-Year Clinical Benefits
PARAGON Study Confirms Sustained Efficacy and Safety of NEUROMARK® System in Allergic and Nonallergic Rhinitis Patients GALWAY, Ireland,…
Why GE HealthCare (GEHC) Shares Are Trading Lower Today
Shares of healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) fell 4.3% in the afternoon session after the U.S.…
Sleep Aids Market to Hit US$ 118.97 Billion by 2033, Growing at 7.8% CAGR
AUSTIN, Texas and TOKYO, Sept. 19, 2025 /PRNewswire/ — According to DataM Intelligence, the global sleep aids market…
In Vitro Diagnostics (IVD) Quality Control Market worth $2.15 billion by 2030 with 5.5% CAGR
DELRAY BEACH, Fla., Sept. 19, 2025 /PRNewswire/ — The global In Vitro Diagnostics Quality Control Market, valued at…